Proefschrift

Dong, L., Zieren, R., Xue, W., de Reijke, T., and Pienta, K. (2019). Metastatic prostate cancer remains incurable, why? Asian Journal of Urology , 6(1):26–41. 3 Ducreux, M., Caramella, C., Hollebecque, A., Burtin, P., Go´er´e, D., Seufferlein, T., Haustermans, K., Van Laethem, J., Conroy, T., and Arnold, D. (2015). Cancer of the pancreas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals of Oncology , 26(suppl 5):v56–v68. 115 Ellison, L. and Wilkins, K. (2010). An update on cancer survival. Health Reports , 21(3):55– 60. 115 Engelhart, M., Lebiedz, D., and Sager, S. (2011). Optimal control for selected cancer chemotherapy ODE models: A view on the potential of optimal schedules and choice of objective function. Mathematical Biosciences , 229(1):123–134. 14, 64 Enriquez-Navas, P., Kam, Y., Das, T., Hassan, S., Silva, A., Foroutan, P., Ruiz, E., Martinez, G., Minton, S., Gillies, R., and Gatenby, R. (2016). Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer. Science Translational Medicine , 8(327):327ra24. 11, 23, 49, 63, 82, 88, 97 Enriquez-Navas, P., Wojtkowiak, J., and Gatenby, R. (2015). Application of evolutionary principles to cancer therapy. Cancer Research , 75(22):4675–4680. 49 Evans, J., Qiu, M., MacKinnon, M., Green, E., Peterson, K., and Kaizer, L. (2016). A multi-method review of home-based chemotherapy. European Journal of Cancer Care , 25(5):883–902. 98 Fair, R. and Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry , 6:PMC–S14459. 6 Fernandez-Cornejo, J. (1998). Environmental and economic consequences of technology adoption: IPM in viticulture. Agricultural Economics: The Journal of the International Association of Agricultural Economists , 18(968-2016-75735):145–155. 9 Fischer, A., V´azquez-Garc´ıa, I., and Mustonen, V. (2015). The value of monitoring to control evolving populations. Proceedings of the National Academy of Sciences , 112(4):1007–1012. 97 Fizazi, K., Tran, N., Fein, L., Matsubara, N., Rodriguez-Antolin, A., Alekseev, B., O¨ zgu¨ro˘glu, M., Ye, D., Feyerabend, S., Protheroe, A., et al. (2019). Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase III trial. The Lancet Oncology , 20(5):686–700. 90 Fox, J., Gavane, S., Blanc-Autran, E., Nehmeh, S., Go¨nen, M., Beattie, B., Vargas, H., Scho¨der, H., Humm, J., Fine, S., et al. (2018). Positron emission tomography/computed tomography–based assessments of androgen receptor expression and glycolytic activity as a 171